Success Metrics

Clinical Success Rate
62.5%

Based on 5 completed trials

Completion Rate
63%(5/8)
Active Trials
1(11%)
Results Posted
40%(2 trials)
Terminated
3(33%)

Phase Distribution

Ph phase_2
1
11%
Ph phase_4
1
11%
Ph phase_3
7
78%

Phase Distribution

0

Early Stage

1

Mid Stage

8

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
1(11.1%)
Phase 3Large-scale testing
7(77.8%)
Phase 4Post-market surveillance
1(11.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

62.5%

5 of 8 finished

Non-Completion Rate

37.5%

3 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(5)
Terminated(3)

Detailed Status

Completed5
Terminated3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
62.5%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (11.1%)
Phase 37 (77.8%)
Phase 41 (11.1%)

Trials by Status

completed556%
terminated333%
recruiting111%

Recent Activity

1 active trials
Showing 5 of 9
recruitingphase_3

A Trial to Compare Nebulized Amphotericin B and Nebulized Normal Saline as Maintenance in Patients With Chronic Pulmonary Aspergillosis

NCT06447402
terminatedphase_2

Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)

NCT01945281
terminatedphase_4

Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil

NCT01310738
terminatedphase_3

Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal Candidiasis

NCT00815516
completedphase_3

Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer

NCT00002742
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT06447402Phase 3

A Trial to Compare Nebulized Amphotericin B and Nebulized Normal Saline as Maintenance in Patients With Chronic Pulmonary Aspergillosis

Recruiting
NCT01945281Phase 2

Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)

Terminated
NCT01310738Phase 4

Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil

Terminated
NCT00815516Phase 3

Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal Candidiasis

Terminated
NCT00002742Phase 3

Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer

Completed
NCT00003031Phase 3

Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis

Completed
NCT00523965Phase 3

Combination Therapy in Indian Visceral Leishmaniasis

Completed
NCT00696969Phase 3

Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis

Completed
NCT00628719Phase 3

Single Infusion of Liposomal Amphotericin B in Indian Visceral Leishmaniasis

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9